Veterinary Clinical Trials Market Report 2026

Veterinary Clinical Trials Market Overview

• Veterinary Clinical Trials market size has reached to $4.85 billion in 2025 • Expected to grow to $7.61 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Impact of Rising Pet Ownership On The Growth Of The Veterinary Clinical Trials Market • Market Trend: Advancements In Anti-Aging Drugs For Senior Dogs Enhancing Longevity And Quality Of Life • North America was the largest region in 2025.

What Is Covered Under Veterinary Clinical Trials Market?

Veterinary clinical trials are research studies conducted to evaluate the safety, efficacy, and outcomes of new treatments, medications, or medical devices for animals. These trials follow structured protocols and are designed to assess how well a therapeutic intervention works in preventing, diagnosing, or treating animal health conditions. The main animals of veterinary clinical trials are livestock animals, companion animals, and others. Livestock animals refer to domesticated animals raised for agricultural purposes, including meat, milk, eggs, wool, and other products. They typically include species such as cattle, sheep, pigs, goats, and poultry. These animals are treated for various indications such as oncology, internal medicine, orthopedics, cardiology, neurology, ophthalmology, dermatology, and others, with interventions including medicines, medical devices, and others. End users include academic and research centers, pharmaceutical and biopharmaceutical companies, and others.

What Is The Veterinary Clinical Trials Market Growth Forecast?

The veterinary clinical trials market size is expected to see strong growth in the next few years. It will grow to $7.61 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to increasing investments in veterinary drug development, rising adoption of precision medicine for animals, expansion of CRO involvement in veterinary trials, growing focus on chronic and oncology indications, increased use of real-world evidence in animal health. Major trends in the forecast period include increasing adoption of digital trial management platforms, rising use of genomic and biomarker-based studies, growing focus on companion animal clinical research, expansion of multicenter veterinary trials, enhanced emphasis on data integrity and compliance.

Global Veterinary Clinical Trials Market Segmentation

1) By Animal: Livestock Animal, Companion Animal, Other Animals 2) By Indications: Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, Other Indications 3) By Intervention: Medicines, Medical Devices, Other Interventions 4) By End-Users: Academics And Research Centers, Pharmaceutical And Biopharmaceutical Companies, Other End-Users Subsegments: 1) By Livestock Animal: Cattle, Sheep, Goats, Swine, Poultry 2) By Companion Animal: Dogs, Cats, Horses, Rabbits, Ferrets 3) By Other Animals: Wildlife, Exotic Pets, Laboratory Animals, Aquatic Animals

What Is The Driver Of The Veterinary Clinical Trials Market?

The rising number of pet owners is expected to propel the growth of the veterinary clinical trials market going forward. Pet ownership refers to the act of having and caring for one or more animals as domestic companions. The increasing pet ownership can be attributed to several factors, including the desire for companionship, the benefits of pet therapy, and the growing awareness of the positive impact pets have on mental and physical well-being. Pet ownership benefits from veterinary clinical trials by improving access to cutting-edge treatments for pets and advancing veterinary care, ensuring better health outcomes for animals. These trials also contribute to developing safer and more effective treatments. For instance, in June 2025, according to Petfood Industry, a US-based pet food manufacturer, approximately 68 million dogs were owned by American households in the most current survey, up from 65.1 million in the 2023–2024 study. Therefore, the rising number of pet owners is driving the growth of the veterinary clinical trials industry.

Key Players In The Global Veterinary Clinical Trials Market

Major companies operating in the veterinary clinical trials market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Charles River Laboratories International Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Hill's Pet Nutrition Inc., Ethos Veterinary Health LLC, Orion Corporation, Dechra Pharmaceuticals plc, Morris Animal Foundation, Vaxine Pty Ltd, Bioagile Therapeutics Pvt. Ltd., VetStem Inc., VetDC, Vivesto AB, OCRvet, Vetbiolix, Clinvet International, Ondax Scientific S.l., Veterinary Research Management

Global Veterinary Clinical Trials Market Trends and Insights

Major companies operating in the veterinary clinical trials market are focusing on developing novel anti-aging drugs to enhance pet longevity and improve overall animal health. Novel anti-aging drugs refer to innovative medications designed to slow down or reverse the aging process and improve the health and vitality of aging animals. For instance, in February 2024, Loyal, a US-based veterinary company, launched a clinical trial for a novel anti-aging drug, LOY-002, to extend senior dogs' healthy lifespan. It is designed to improve metabolic health in dogs, targeting age-related changes that can lead to various health issues. This chewable pill, specifically designed for older dogs of most sizes (excluding the smallest breeds), is currently being tested in the STAY study, which plans to recruit over 1,000 dogs aged 10 and older across more than 50 veterinary clinics in the United States. The primary objective of LOY-002 is to enhance metabolic function, potentially delaying age-related diseases and boosting the overall quality of life for aging dogs.

What Are Latest Mergers And Acquisitions In The Veterinary Clinical Trials Market?

In September 2024, Boehringer Ingelheim Group, a Germany-based pharmaceutical manufacturing company, acquired Saiba Animal Health AG for an undisclosed amount. With the acquisition, Boehringer Ingelheim enhances its animal health research and development pipeline, particularly in the rapidly expanding pet therapeutics sector, by integrating an innovative technology platform into its pet therapeutics research and development portfolio. Saiba Animal Health AG is a Switzerland-based biotechnology research company that specializes in creating new therapeutic medicines to tackle chronic diseases in pets.

Regional Outlook

North America was the largest region in the veterinary clinical trials market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Veterinary Clinical Trials Market?

The veterinary clinical trials market includes revenues earned by entities by providing services such as study design and protocol development, regulatory compliance and submission, data collection and analysis, and monitoring and quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Clinical Trials Market Report 2026?

The veterinary clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.